Keysight Technologies Applauded by Frost & Sullivan for Enhancing Threat Detection and Response Capabilities with Its Electronic Warfare and Spectrum Management Solutions
Keysight's EW solutions counter advanced and evolving threats and offer scalability and…
Incyclix Bio Announces Publication in Nature Communications Highlighting Biomarkers of Response to CDK2 Inhibition
February 13, 2025 08:00 ET | Source: Incyclix Bio RESEARCH TRIANGLE PARK,…
New York Blood Center Enterprises Researchers Identify New Immune Response Mechanisms in Sickle Cell Disease
February 12, 2025 09:00 ET | Source: New York Blood Center Enterprises…
Pfizers BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial…
Pfizers BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial…
Frost & Sullivan Recognizes RapidSOS with the 2024 Product Leadership Award for Enhancing Public Safety Through Next-Gen Emergency Response Technology
RapidSOS's transformative platforms leverage artificial intelligence (AI) and connected data from over…
CCTV+: 2024 Beijing Forum on Swift Response to Public Complaints opens in Beijing
BEIJING, Dec. 19, 2024 /PRNewswire/ -- The 2024 Beijing Forum on Swift…
Zomato Launches Accelerated Safety Response Program for Delivery Partners
New Feature Automatically Detects Crashes and Dispatches Emergency Assistance, Reinforcing Zomato's Commitment…
AV-Comparatives Announces Outstanding Results of Cybersecurity Solutions in 2024 Endpoint Prevention and Response (EPR) Test
Download the full report here. INNSBRUCK, Austria, Dec. 11, 2024 /PRNewswire/ --…
Investigational Epcoritamab (DuoBody CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis
Media ReleaseCOPENHAGEN, Denmark; December 8, 2024 Preliminary analyses from the EPCORE® CLL-1…